IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs - Shares Magazine

Retrieved on: 2022-05-30 11:50:44

Tags for this article:

Click the tags to see associated articles and topics

IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs - Shares Magazine. View article details on hiswai:

Excerpt

Firm expects 'to create a range of monoclonal antibodies and reagents' regarding its lung-cancer focused collaboration with Portugal-based ...

Article found on: www.sharesmagazine.co.uk